[go: up one dir, main page]

ATE90673T1 - Antifolat-mittel. - Google Patents

Antifolat-mittel.

Info

Publication number
ATE90673T1
ATE90673T1 AT87907792T AT87907792T ATE90673T1 AT E90673 T1 ATE90673 T1 AT E90673T1 AT 87907792 T AT87907792 T AT 87907792T AT 87907792 T AT87907792 T AT 87907792T AT E90673 T1 ATE90673 T1 AT E90673T1
Authority
AT
Austria
Prior art keywords
alkyl
agents
group
formula
compounds
Prior art date
Application number
AT87907792T
Other languages
English (en)
Inventor
Malcolm Francis Graham Stevens
Roger John Griffin
Michelle Anne Nee Mee Robinson
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628731A external-priority patent/GB8628731D0/en
Priority claimed from GB878721283A external-priority patent/GB8721283D0/en
Priority claimed from GB878721284A external-priority patent/GB8721284D0/en
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE90673T1 publication Critical patent/ATE90673T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT87907792T 1986-12-02 1987-11-30 Antifolat-mittel. ATE90673T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB868628731A GB8628731D0 (en) 1986-12-02 1986-12-02 Antifolate agents
GB878721283A GB8721283D0 (en) 1987-09-10 1987-09-10 Antifolate agents
GB878721284A GB8721284D0 (en) 1987-09-10 1987-09-10 Antifolate agents
EP87907792A EP0290558B1 (de) 1986-12-02 1987-11-30 Antifolat-mittel
PCT/GB1987/000859 WO1988004293A1 (en) 1986-12-02 1987-11-30 Antifolate agents

Publications (1)

Publication Number Publication Date
ATE90673T1 true ATE90673T1 (de) 1993-07-15

Family

ID=27263226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907792T ATE90673T1 (de) 1986-12-02 1987-11-30 Antifolat-mittel.

Country Status (7)

Country Link
US (1) US4992444A (de)
EP (1) EP0290558B1 (de)
JP (1) JP2704747B2 (de)
AT (1) ATE90673T1 (de)
DE (1) DE3786256T2 (de)
GB (1) GB2204867B (de)
WO (1) WO1988004293A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226377D0 (en) * 1992-12-18 1993-02-10 Babbedge Rachel C Pharmaceutical compositions
WO1994014780A1 (en) * 1992-12-18 1994-07-07 The Wellcome Foundation Limited Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
GB9700664D0 (en) * 1997-01-14 1997-03-05 British Tech Group Anti-cancer agents
US7371758B2 (en) * 2003-03-13 2008-05-13 National Science & Technology Development Agency Antimalarial pyrimidine derivatives and methods of making and using them
US20050171132A1 (en) * 2003-09-26 2005-08-04 Zhili Xin Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
WO2014145386A2 (en) * 2013-03-15 2014-09-18 University Of Florida Research Foundation Incorporated Novel allosteric inhibitors of thymidylate synthase
WO2016209688A1 (en) 2015-06-24 2016-12-29 University Of Florida Research Foundation, Incorporated Compositions for the treatment of cancer and uses thereof
WO2023081141A1 (en) * 2021-11-02 2023-05-11 University Of Florida Research Foundation, Incorporated Thymidylate synthase inhibitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903850A1 (de) * 1979-02-01 1980-08-07 Bayer Ag 2-amino-8-cyclopropyl-5-oxo-5,8- dihydro-pyrido eckige klammer auf 2,3-d eckige klammer zu -pyrimidin-6-carnonsaeuren, verfahren zu ihrer herstellung sowie ihrer verwendung als antibakterielle mittel
GB8314643D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Pyrimidine derivatives
GB8410636D0 (en) * 1984-04-26 1984-05-31 Stevens M F G Pharmaceutical substances/compositions

Also Published As

Publication number Publication date
DE3786256T2 (de) 1993-10-07
US4992444A (en) 1991-02-12
JP2704747B2 (ja) 1998-01-26
GB2204867B (en) 1991-05-29
GB8728018D0 (en) 1988-01-06
EP0290558A1 (de) 1988-11-17
GB2204867A (en) 1988-11-23
JPH01501477A (ja) 1989-05-25
WO1988004293A1 (en) 1988-06-16
EP0290558B1 (de) 1993-06-16
DE3786256D1 (de) 1993-07-22

Similar Documents

Publication Publication Date Title
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NZ504336A (en) Tetrahydrofuran substituted adenosine A1 receptor agonists, pharmaceuticals thereof, and their use as medicaments
FI900085A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
FI884375A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
NO921413L (no) Pyrazolopyridin-forbindelser og fremgangsmaate for fremstilling derav
ATE90673T1 (de) Antifolat-mittel.
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
ATE84035T1 (de) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2- one.
CA2440014A1 (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
ES547620A0 (es) Procedimiento para preparar pirazol (3,4-b) piridinamidas.
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
GB2152508A (en) Pyrimidine derivatives
MY106786A (en) Novel antiviral tetrahydroimidazo [1,4] benzodiazepin -2- (thi)ones
FR2457868A1 (fr) Derives de l'imidazobenzodiazepine, leur preparation et leurs utilisations therapeutiques
SE8206230L (sv) Nya cykliska iminderivat, sett for deras framstellning och farmaceutiska beredningar innehallande dem
HUT73528A (en) 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
TH5602A (th) สารประกอบทางเภสัชวิทยาชนิดใหม่
PT89483A (pt) Processo para a preparacao de derivados da 2-amino acetamida
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.
FR2224152A1 (en) Thiazolotriazolyl phosphorothioates as anthelmintics - combining good anthelmintic activity with low toxicity to warm-blooded animals
SE8704049D0 (sv) Novel pharmacological compounds